LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

Thermo Fisher köper svenskägt bolag i mångmiljardaffär

Thermo Fisher Scientific förvärvar hälsoteknikbolaget Clario i en affär värderad till 9,4 miljarder dollar.

Partial court victory for entrepreneur who lost his company

Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...

Swedish life science is growing – but capital is not keeping up

The number of employees and companies in Swedish life science is increasing and the sector is more equal than many other sectors. But investments in unlisted co...

Galenica AB

The Future of Metrology is Coming to Your Region

Join our event series.

Meet us at Control 2025

Innovations that drive efficiency.

Discover Precision: Join ZEISS at the Control Fair in Stuttgart

May 6-9, 2025 in Stuttgart. Hall 9, Booth 9309.

Bioscience – Groundbreaking Research & Diagnostics: Stockholm (2025)

Security flaw in Swedish breast cancer screening software – woman passed away

A lack of safeguard in Sectra's software led to a woman with breast cancer receiving an incorrect diagnosis. She later passed away. The software is used in 20 o...

Product demo with features, software and best-practices

Get interesting insights about ZEISS O-INSPECT duo in our demo recording.

Medical Plastics Tips & Tricks

Measuringhero video by ZEISS.

ZEISS EVO as the Key to Wire Technology in Modern Medicine

High-performance wires for stents.

Join us for a Life Science seminar on april 9th on GoCo

Festo products and solutions are setting the stage for better health through innovative solutions for reliable medical technology and precise, reproducible labo...

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2025)

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

Merck Life Science A/S

100 years of Festo

The spirit of invention is deeply rooted in our corporate culture. Since our foundation, we have been setting benchmarks by developing innovative solutions that...

Astra Zeneca’s asthma drug nears approval for sinus inflammation

Astra Zeneca’s drug Tezspire receives positive opinion from the European Medicines Agency (EMA) for the treatment of chronic rhinosinusitis with nasal polyps.

Korbinian Löbmann leads scientific meeting on drug formulation: High activity in the field

Korbinian Löbmann has moderated New Updates in Drug Formulation & Bioavailability several times before. Now he is once again taking on the scientific meeting. L...

Karolinska och Akademiska utökar ATMP-samarbete

Ett fördjupat samarbete mellan Karolinskas centrum för avancerade terapier och motsvarande centrum i Uppsala syftar till att ge fler patienter tillgång till cel...